AdvisorShares Pure Cannabis ETF (YOLO)
| Assets | $42.06M |
| Expense Ratio | 1.12% |
| PE Ratio | 21.88 |
| Shares Out | 12.78M |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| Volume | 33,162 |
| Open | 3.250 |
| Previous Close | 3.270 |
| Day's Range | 3.130 - 3.250 |
| 52-Week Low | 1.450 |
| 52-Week High | 3.940 |
| Beta | 1.36 |
| Holdings | 21 |
| Inception Date | Apr 17, 2019 |
About YOLO
Fund Home PageThe AdvisorShares Pure Cannabis ETF (YOLO) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively-managed ETF that seeks long-term capital appreciation by investing in both domestic and foreign cannabis equities, as well as total return swaps of similar securities. YOLO was launched on Apr 17, 2019 and is issued by AdvisorShares.
Top 10 Holdings
93.57% of assets| Name | Symbol | Weight |
|---|---|---|
| AdvisorShares Pure US Cannabis ETF | MSOS | 40.67% |
| Village Farms International, Inc. | VFF | 19.30% |
| High Tide Inc. | HITI | 11.16% |
| SNDL Inc. | SNDL | 5.74% |
| Cronos Group Inc. | CRON | 4.68% |
| Organigram Global Inc. | OGI | 4.19% |
| Tilray Brands, Inc. | TLRY | 2.41% |
| Aurora Cannabis Inc. | ACB | 2.28% |
| Jazz Pharmaceuticals plc | JAZZ | 1.62% |
| Cardiol Therapeutics Inc. | CRDL | 1.51% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 23, 2024 | $0.0405 | Sep 30, 2024 |
| Jun 24, 2024 | $0.01782 | Jun 28, 2024 |
| Mar 21, 2024 | $0.02813 | Mar 28, 2024 |
| Dec 26, 2023 | $0.00778 | Dec 29, 2023 |
| Sep 25, 2023 | $0.00561 | Sep 29, 2023 |
| Jun 22, 2023 | $0.01085 | Jun 30, 2023 |
Performance
YOLO had a total return of -10.03% in the past year, including dividends. Since the fund's inception, the average annual return has been -25.74%.
News
Disruptive Theme of the Week: Top YTD Themes in the Rearview Mirror
It may not be the end of the quarter yet, but we have made it through summer, and that seems like a good checkpoint to evaluate the top ETF investment themes YTD. Let's take a moment to look in this y...
Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization
Amendment 3 – which would have legalized the recreational use of marijuana in the state's constitution – failed to receive the 60% support needed to pass under Florida law.
AdvisorShares Highlights the Pending Historic Reforms in US Cannabis Market
With cannabis approaching a pivotal juncture, AdvisorShares provides key investment exposure to multi-state operators through its industry-leading ETF suite BETHESDA, Md. , Oct. 21, 2024 /PRNewswire/ ...
Investors wary of US cannabis ETFs despite recent rally
Marijuana ETFs and cannabis stocks shot higher last week after the U.S. Justice Department said it plans to reclassify marijuana as a less dangerous drug.
Marijuana reclassified federally in major win for the legal cannabis industry
The U.S. government will reclassify marijuana as less risky as the recreational marijuana business continues to grow.
Biden Administration Moving Marijuana To Less Severe Drug Class—Boosting Medical Uses, Reports Say
The Drug Enforcement Administration is reportedly planning to reclassify marijuana so it is no longer categorized as one of the most dangerous and addictive drugs—a decision that would fall short of l...
Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug
Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug.
Biden administration to ease federal restrictions on marijuana
CNBC's Brandon Gomez joins 'Power Lunch' to discuss the Biden administration's plan to reclassify marijuana, easing federal restrictions.
Finding The Long-Term Winners In The Cannabis Sector, December 2023 Update
This article attempts to assess and rank the relative growth potential of the separate competitors in the cannabis industry. Long-term trends show projected growth in the U.S., Canadian, and global ca...
Reasons To Be Cautiously Optimistic About Cannabis
Cautious optimism is warranted in the cannabis industry due to potential changes, such as the move to federal legalization and improved fundamentals. Investors should consider their risk appetite, tim...
A key Marijuana financing bill moves forward in the U.S. Senate
Cannabis stocks are in focus after the Secure and Fair Enforcement Regulation Banking Act moved forward in the upper chamber of Congress on Wednesday. What the renegotiated SAFER means for cannabis co...
YOLO: Reintroduction Of SAFE Banking Act Creating New Opportunities For Cannabis ETFs
YOLO invests in cannabis companies that are both pharmaceutical and recreational in nature. YOLO and similar funds have struggled to gain momentum during the past two years amid various financial and ...
Top Cannabis ETFs To Watch Mid February
Are Cannabis ETFs On Your Watchlist Right Now? The post Top Cannabis ETFs To Watch Mid February appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Top Marijuana ETFs To Watch In 2023
Are Cannabis ETFs Good Long-Term Investments In 2023? The post Top Marijuana ETFs To Watch In 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Markets Don't Move In Straight Lines
The most consistent progress in cannabis is coming from states continuing to roll out legalization programs. For cannabis companies wanting to make a profit in these legal markets, there is both oppor...
What's The Deal With New York Cannabis?
Legal cannabis has officially hit New York. Two long-time NY advocates, Allan Gandelman and Kaelan Castetter, provide context for this moment.
New Year, No Fear
New years are a time for reflection, especially those that follow tough years filled with challenging lessons. Hopium and corruption (or its close relative, greed) are thriving in these volatile days.
Top Cannabis ETF's To Buy Now? 4 For Your 2023 Watchlist
Best ETFs to Watch In The Cannabis Industry The post Top Cannabis ETF's To Buy Now? 4 For Your 2023 Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Ind...
Top Cannabis ETFs To Watch In December
Are Top Marijuana ETFs A Buy In 2022? The post Top Cannabis ETFs To Watch In December appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Beware Canada 2.0 (Transcript)
Julian Lin tells investors to focus on MSOs that can generate free cash flow right now. Price compression has been far more severe than expected.
Beware Canada 2.0
With tech stocks crashing, are cannabis stocks the most compelling investment right now? Julian Lin tells investors to focus on MSOs that can generate free cash flow right now.
YOLO: The Legal Way To Buy Cannabis
The AdvisorShares Pure Cannabis ETF invests in both foreign and domestic cannabis equities. Since its inception in 2019, YOLO has dropped in price by 38%.
Looking To Invest In The Cannabis Industry? 4 Marijuana ETFs To Watch
Is It Time To Invest Long Term In Cannabis Stocks? The post Looking To Invest In The Cannabis Industry? 4 Marijuana ETFs To Watch appeared first on Marijuana Stocks | Cannabis Investments and News. Ro...
Marijuana stocks surge after Biden pardons weed offenders
Shares of Florida-based Trulieve Cannabis were trading as much as 47% higher at one point early Friday morning.
Investing In Marijuana Stocks Right Now? 4 Cannabis ETFs For Long Term
Is It Time To Invest In Cannabis ETFs In 2022? The post Investing In Marijuana Stocks Right Now? 4 Cannabis ETFs For Long Term appeared first on Marijuana Stocks | Cannabis Investments and News. Roots...
Cannabis REITs: Too Cheap To Get High
The previously high-flying cannabis REITs have been slammed this year on concerns over rent payment from their cannabis cultivator tenants, which have been struggling amid a plunge in wholesale cannab...
CPG And Cannabis - A Conversation With Troy Datcher (Podcast Transcript)
Coming from the blue chip CPG world, CEO Troy Datcher joined The Parent Company last year. Fresh off earnings, we discussed getting rid of inflated topline sales and why main competition is the illici...
Cannabis Consumption (Podcast Transcript)
How do you consume cannabis? A fascinating conversation with Lauren Fontein and Courtney Caron of The Artist Tree, a beautiful new consumption lounge, on the developing retail landscape.
Evaluating Advisor Shares Cannabis ETFs
We now have 37 states, plus Washington DC, that offer some form of medical or adult-use cannabis. MSOS is the largest cannabis ETF with approximately $650 million in assets.
Here Is Whats New In The Cannabis Industry
What Is New In The Cannabis Industry Right Now? The post Here Is Whats New In The Cannabis Industry appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Cannabis Valuations Within A Growing Green Map
Federal legalization as a catalyst and what happens to valuations if we're years away. Growth industries: Comparing undervalued tech to cannabis stocks.
Cannabis REITs: Weeding Out The Weak
Cannabis REITs - a perennial performance leader over the past half-decade - have been slammed in 2022 amid concerns over tenant financial health given the sharp re-pricing of risk and tighter financia...
Best Marijuana ETFs To Buy In 2022? 4 For Your Watchlist In Q2
Is It Time To Start Nibbling On Top Marijuana ETFs Right Now? The post Best Marijuana ETFs To Buy In 2022? 4 For Your Watchlist In Q2 appeared first on Marijuana Stocks | Cannabis Investments and News...
These are the new rules for investors who want to buy marijuana stocks
If technology stocks are causing you pain, just be thankful you don't own cannabis shares.
Top Marijuana ETFs To Buy In 2022? 4 For Your Watchlist In April
Best Cannabis ETFs For April 2022 The post Top Marijuana ETFs To Buy In 2022? 4 For Your Watchlist In April appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Indus...
This ETF Will Grow Like A Weed, YOLO!
Cannabis legalization continues to progress, supporting growth rates. Financial normalization is also happening, allowing companies to report stronger earnings.